期刊文献+

盐酸曲美他嗪择时渗透泵控释片的制备及含量测定 被引量:1

Preparation and Determination of Trimetazidine Dihydrochloride Pulsatile Osmotic Pump Controlled Release Tablets
下载PDF
导出
摘要 目的:建立盐酸曲美他嗪择时渗透泵控释片中盐酸曲美他嗪的高效液相色谱含量测定方法。方法:采用Dikma Diamonsil C_(18)色谱柱(250 mm×4.6 mm,5μm),以0.02 mol·L^(-1)乙酸铵(含0.5%三乙胺)-甲醇(50:50)为流动相,流速为1.0 ml·min^(-1),检测波长为232 nm.进样量20μl。结果:在此色谱条件下,盐酸曲美他嗪浓度与峰面积在6.0~16.8μg·ml^(-1)内线性关系良好,r=0.999 5,平均回收率为99.6%,RSD为1.04%(n=9)。结论:本方法灵敏度高,快速准确,可用于盐酸曲美他嗪择时控释片的质量控制。 Objective;To eslablish an HPLC method for the determination of trimetazidine dihydrochloride pulsatile controlled release tablets.Method:A Dikma Diamonsil C18 column(250 mm×4.6 mm,5μm)was used,the mobile phase consisted of0.02 mol ? L-1 ammonium acetate(including 0.5%triethylamine)-methanol(50:50) with a flow rate of 1.0 ml?min-1,the detection wavelength was 232nm,and the injection volume was 20μl.Result:The linear range of trimetazidine dihydrochloride was 6.0-16.8 μg? ml-1(r=0.999 5).The recovery was 99.6%with RSD of 1.04%(n =9).Conclusion;The method is sensitive,rapid and accurate,and can be used in the quality control of trimetazidine dihydrochloride pulsatile controlled release tablets.
出处 《中国药师》 CAS 2013年第12期1781-1784,共4页 China Pharmacist
基金 国家"十二五"科技重大专项经费资助课题(编号:2013ZX09J13109-05C)
关键词 盐酸曲美他嗪 择时 渗透泵 控释片 含量测定 高效液相色谱 Trimetazidine dihydrochloride Pulsatile Osmotic pump Controlled release tablets Determination HPLC
  • 相关文献

参考文献7

二级参考文献34

  • 1Ciapponi A, Pizarro R, Harrison J. Trimetazidine for stable angina [ J ]. Cochrane Database Syst Rev, 2005,19 ( 4 ) : CD003614.
  • 2Fox K, Garcia MA, Ardissino D, et al. Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology[J]. Eur Heart J,2006,27(11 ):1341-1381.
  • 3Fraker TD Jr, Fihn SD, Gibbons RJ ,et al. 2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina [ J ]. Circulation, 2007, 116 ( 23 ) : 2762-2772.
  • 4Bonello L, Sbragia P, Amabile N, et al. Protective effect of an acute oral loading dose of trimetazidine on myocardial injury, following percutaneous coronary intervention [ J ]. Heart, 2007,93 ( 6 ) : 703 -707.
  • 5Polonski L, Dec I, Wojnar R, et al. Trimetazidine limits the effects of myocardial ischaemia during percutaneous coronary angioplasty [J]. Curr Med Res Opin,2002,18(7) :389-396.
  • 6Steg PG, Grollier G, Gallay P, et al. A randomized double-blind trial of intravenous trimetazidine as adjunctive therapy to primary angioplasty for acute myocardial infarction [ J ]. Int J Cardio1,2001, 77 ( 2/3 ) :263-273.
  • 7Kuralay F, Altekin E, Yazlar AS, et al. Suppression of angioplastyrelated inflammation by pre-procedural treatment with trimetazidine [ J ]. Tohoku J Exo M ed ,2006,208 (3) :203-212.
  • 8Feola M, Biggi A, Francini A, et al. Placebo or trimetazidine ( 99m ) Tc tetrofosmin myocardial SPECT and low-dose dobutamine echocardiography in hibernating myocardium[ J]. Arch Med Res,2006, 37(1) :117-122.
  • 9Tereshchenko SN, Golubev AV, Kositsyna IV, et al. Trimetazidine in complex therapy of acute myocardial infarction at the background of diabetes mellitus type 2 [J]. Kardiologiia,2006,45 (1) :31-34.
  • 10Guler N, Eryonucu B, Gunes A, et al. Effects of trimetazidine on submaximal exercise test in patients with acute myocardial infarction [ J ]. Cardlovasc Drugs Ther,2003,17 (4) :371-374.

共引文献381

同被引文献15

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部